Junko Murai

Genetics meets Chemical Biology

Shunichi Takeda, Junko Murai, 2014 .

Rationale for Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Combination Therapy with Camptothecins or Temozolomide Based on PARP Trapping versus Catalytic Inhibition

James H. Doroshow, Yves Pommier, Shunichi Takeda, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Discovery and Structure–Activity Relationship of Novel 2,3-Dihydrobenzofuran-7-carboxamide and 2,3-Dihydrobenzofuran-3(2H)-one-7-carboxamide Derivatives as Poly(ADP-ribose)polymerase-1 Inhibitors

Frank R. Fronczek, Yves Pommier, Junko Murai, 2014, Journal of medicinal chemistry.

A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress

Yves Pommier, Junko Murai, Justin R Pritchard, 2017, Nature Medicine.

Differential and Common DNA Repair Pathways for Topoisomerase I- and II-Targeted Drugs in a Genetic DT40 Repair Cell Screen Panel

Yves Pommier, Shunichi Takeda, Junko Murai, 2013, Molecular Cancer Therapeutics.